Bolt Biotherapeutics, Inc
Price
FilingsNewest: 8-K, Material agreementOct 6 →Insiders2 insiders bought $1,152 in 2 open-market buys. No sales.→HoldersSofinnova Investments 7.1%Renaissance Technologies 5.1%Vivo Capital 3.8%→
From the filings
Figures
- Revenue
- $4.7Mlast 12 months
- Net income
- −$28.7Mlast 12 months
- Operating cash flow
- −$34.5Mlast 12 months
- Cash and equivalents
- $12.9Mat the last balance sheet
- Shares outstanding
- 1.9M shareson issue